Integrating medical abortion into safe abortion services: Experience from three pilot sites in South Africa

Journal of Family Planning and Reproductive Health Care

Volumn 34, Issue 3, 2008, Pages 159-164

  Kawonga, Mary ^a   Blanchard, Kelly ^b   Cooper, Diane ^c   Cullingworth, Lee ^c   Dickson, Kim ^e   Harrison, Teresa ^d   Von Mollendorf, Claire ^e   Winikoff, Beverly ^f  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b IBIS REPRODUCTIVE HEALTH   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Statistics and Public Health Research Division   (United States)

^e Reproductive Health and HIV Research Unit   (South Africa)

^f GYNUITY HEALTH PROJECTS   (United States)

Author keywords

Medical abortion; Mifepristone; Misoprostol; Public sector safe abortion services; South Africa

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; BLEEDING; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ABORTION; PAIN; PATIENT SATISFACTION; PREGNANCY OUTCOME; SOUTH AFRICA;

ABORTION, INDUCED; ABORTION, THERAPEUTIC; ADULT; FAMILY PLANNING SERVICES; FEASIBILITY STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PREGNANCY; PROSPECTIVE STUDIES; SAFETY; SOUTH AFRICA;

EID: 47249106450     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118908784734846     Document Type: Article

References (25)

1. Kahn JG, Becker BJ, MacIsaa L, Amory JK, Neuhaus J, Olkin I, et al. The efficacy of medical abortion: a meta-analysis. Contraception 2000; 61: 29-40.
2. Peyron R, Aubény E, Targosz V, Silvestre L, Renault M, Elkik F, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328: 1509-1513.
3. El-Rafaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983-987.
4. Grimes D. Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol 1997; 89: 790-796.
5. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338: 1241-1247.
6. Winikoff B, Sivin I, Coyaji KJ, Cabezas E, Xiao B, Gu S, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 1997; 176: 431-437.
7. Coyaji K, Elul B, Krishna U, Otiv S, Ambardekar S, Bopardikar A, et al. Mifepristone abortion outside the urban research hospital setting in India. Lancet 2001; 357(9520): 120-122.
8. Henderson JT, Hwang AC, Harper CC, Stewart FH. Safety of mifepristone abortions in clinical use. Contraception 2005; 72: 175-178.
9. Jones RK, Henshaw SK. Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden. Perspect Sex Reprod Health 2002; 34: 154-161.
10. Elul B, Hajri S, Ngoc NN, Ellerston C, Slama CB, Pearlman E, et al. Can women in less-developed countries use a simplified medical abortion regimen? Lancet 2001; 357(9266): 1402-1405.
11. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br J Obstet Gynaecol 2000; 107: 524-530.
12. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999; 59: 1-6.
13. Akin A, Blum J, Ozalp S, Ondero_lu L, Kirca U, Bilgili N, et al. Results and lessons learned from a small medical abortion clinical study in Turkey. Contraception 2004; 70: 401-406.
14. Hajri S, Blum J, Gueddana N, Saadi H, Maazoun L, Chélli H, et al. Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study. Contraception 2004; 70: 487-491.
15. Department of Health. Choice on Termination of Pregnancy Act, 1996 (Act 92 of 1996). Pretoria, South Africa: Department of Health, 1996.
16. Department of Health. Termination of Pregnancy Implementation Guidelines. Pretoria, South Africa: National Directorate of Maternal, Child and Women's Health (not dated).
17. Blanchard K, Shochet T, Coyaji K, Ngoc NTN, Winikoff B. Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception 2005; 72: 91-97.
18. Blanchard K, Taneepanichskul S, Kiriwat O, Sirimai K, Svirirojana N, Mavimbela N, et al. Two regimens of misoprostol for treatment of incomplete abortion. Obstet Gynecol 2004; 103: 860-865.
19. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect 1995; 27: 142-148.
20. Akin A, Dabash R, Dilbaz B, Dursun P, Aktun H, Gokkurt S, et al. Increasing women's choice and access to safe abortion services in Turkey: a study of the efficacy and acceptability of medical abortion in four sites. Reproductive Health 2005 Meeting Abstracts, 7-10 September 2005, St Petersburg, FL. USA. Contraception 2005; 72: 237-238.
21. Cooper D, Dickson K, Blanchard K, Cullingworth L, Brown H, Mavimbela N, et al. Medical abortion: the possibilities for introduction in the public sector in South Africa. Reprod Health Matters 2005; 13: 35-43.
22. Ngoc NT, Winikoff B, Clark S, Ellertson C, Am KN, Do TH, et al. Safety, efficacy and acceptability of mifepristone-misoprostol abortion in Vietnam. Int Fam Plan Perspect 1999; 25: 10-14.
23. Joffe C. Reactions to medical abortion among providers of surgical abortion: an early snapshot. Fam Plann Perspect 1999; 31: 39-43.
24. de Pinho H. Cost Analysis of Abortion Performed in the Public Sector. Cape Town, South Africa: Women's Health Research Unit, Department of Public Health, University of Cape Town, 2000.
25. Cullingworth L, de Pinho H. A Cost Analysis of Service Provision of Medical Abortions in the Public Health Sector at Primary and Secondary Level. Cape Town, South Africa: Women's Health Research Unit, Department of Public Health, University of Cape Town, 2002.